JHP Pharmaceuticals, located in Parsippany, New Jersey, is an integrated
specialty healthcare company that specializes in sterile injectable
products. JHP manufactures and sells brand aseptic injectable
pharmaceuticals in hospital and clinical settings and provides contract
manufacturing services for global pharmaceutical companies. JHP's own
product portfolio includes leading diagnostic, women's health and
anesthesia products. All products have a long track record of "gold
standard" service and are at or near the front line of treatment in
their therapeutic indications. Contract manufactured products include
some of the leading global biologic products which involve liquid,
lyophilized and suspension presentations.
Pitocin ® (oxytocin injection, USP) is a
sterile, clear, colorless aqueous solution
of synthetic oxytocin, for intravenous
infusion or intramuscular injection.
12.31.2012
JHP
Pharmaceuticals Acquired By Warburg
Pincus
JHP Pharmaceuticals, LLC (“JHP”), a
specialty pharmaceutical company
that acquires, develops,
manufactures and sells sterile
injectable products, today announced
that it has been acquired by an
affiliate of Warburg Pincus, a
leading global private equity firm
focused on growth investing, from
JHP Holdings, LLC, an entity
majority-owned by Morgan Stanley
Principal Investments, for $195
million on a debt- free, cash-free
basis.